ban the use of phenylpropanolamine in OTC products
November 2000
Experts are now urging the FDA to ban the use of phenylpropanolamine in OTC products.
This is due to a possible increased risk of hemorrhagic stroke in young women using appetite suppressants...and patients taking cough and cold products that contain phenylpropanolamine (PPA).
Caution patients not to exceed recommended doses of PPA-containing products...Acutrim, Dexatrim, Contac, Dimetapp, etc.
Get concise, unbiased advice for effective drug therapy, plus CE/CME
Prescriber's Letter includes:
- 12 issues every year, with brief articles about new meds and guidelines
- 48+ CE courses, including the popular CE-in-the-Letter
- Quick reference drug comparison charts
- Access to the entire archive
Already a subscriber? Log in
Volume pricing available. Get a quote